Related Experiment Video
Updated: Oct 23, 2025

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
Risk factors for hypertensive phase after Ahmed glaucoma valve implantation
Onur Özalp1, Serdar İlgüy2, Eray Atalay3
1Ophthalmology Clinic, Devrek State Hospital, Zonguldak, Turkey.
Insights
Half of patients experienced a hypertensive phase (HP) after Ahmed glaucoma valve (AGV) implantation. Higher preoperative intraocular pressure and younger age were key risk factors for developing HP.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Intraocular Pressure Management
Background:
- Ahmed glaucoma valve (AGV) implantation is a surgical option for refractory glaucoma.
- Postoperative hypertensive phase (HP) is a potential complication following AGV implantation, necessitating careful monitoring.
Purpose of the Study:
- To identify risk factors and clinical characteristics associated with the hypertensive phase (HP) after Ahmed glaucoma valve (AGV) implantation.
- To analyze the incidence and resolution patterns of HP in patients undergoing AGV surgery.
Main Methods:
- Retrospective study of 60 eyes from 57 patients with at least 1-year follow-up after AGV implantation.
- Hypertensive phase defined as intraocular pressure (IOP) > 21 mmHg within the first 3 months post-surgery.
- Logistic regression analysis employed to determine independent risk factors for HP development.
Main Results:
- Hypertensive phase (HP) occurred in 51.7% of eyes, with an average peak IOP of 27.6 mmHg.
- HP resolved in 87.1% of affected eyes by the 3-month postoperative visit.
- Independent risk factors for HP included preoperative IOP > 30 mmHg and younger age (≤64 years). Traumatic glaucoma showed the highest HP rate (83.3%).
Conclusions:
- The hypertensive phase (HP) is a common occurrence after Ahmed glaucoma valve (AGV) implantation, affecting approximately half of the patients.
- Elevated preoperative intraocular pressure and younger patient age are significant risk factors for developing HP.
- While most cases of HP resolve by three months, affected eyes may require more intensive IOP-lowering management.
Purpose:
To investigate the risk factors and the clinical characteristics of the hypertensive phase (HP) after Ahmed glaucoma valve (AGV) implantation.
Methods:
This retrospective study included 60 eyes of 57 patients who underwent AGV implantation and with at least 1-year follow-up. HP was defined as intraocular pressure (IOP) > 21 mmHg in the first 3 months after the surgery. Independent samples t-test and Chi-square test were used to compare differences in patients with the HP and the non-HP groups. Univariable and multivariable logistic regression analyses were used to determine the risk factors for the development of the HP. Statistical significance was assumed at p < 0.05 level.
Results:
HP was observed in 31 eyes (51.7%) with an average peak IOP of 27.6 ± 4.5 mmHg (range 22-40 mmHg). The resolution of HP was noted in 27 eyes (87.1%) at the 3rd month postoperative visit. The number of glaucoma medications at the last postoperative visit and IOP values from 1 month to 1 year were significantly higher in the HP group (all p < 0.05). Patients with traumatic glaucoma showed the highest rate (83.3%) of HP development. In the multivariable analysis, a preoperative IOP > 30 mmHg (p = 0.03, OR:5.82; reference: ≤ 25 mmHg) and younger age (41-64 years, p = 0.02, OR:8.49; ≤ 40 years, p = 0.001, OR:19.62; reference: ≥ 65 years) were independently associated with the occurrence of HP.
Conclusion:
Hypertensive phase was observed in half of the patients undergoing AGV implantation. A higher mean preoperative IOP and younger age were risk factors for HP development. Although the majority resolved at the 3-month visit, eyes with HP had higher mean IOPs and required more IOP lowering medications.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Aneurysm III: Interprofessional Care
Aortic Regurgitation I: Introduction
Hypertension II: Pathophysiology

